19.48
+8.40%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Mirion Technologies
From its filings with the US Securities and Exchange Commission
Mirion Technologies is based in Atlanta, Georgia. Its shares trade on NYSE under the ticker MIR. The SEC classifies its business as measuring & controlling devices, nec. In the fiscal year to 31 December 2025, it reported revenue of $925.4m and net income of $28.8m. At that date it held total assets of $3.59bn and shareholders' equity of $1.87bn.
At Mirion, we deliver vital protection that unlocks the transformative potential of radiation to move science, industry and medicine forward. For more than 60 years Mirion and our predecessor companies have provided products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. As a global leader in the field of radiation safety and innovation, we bring together unrivaled expertise with an unmatched range of reliably precise technologies.
Safety is at the core of what we do. Through critical nuclear facilities, R&D labs, cancer centers, diagnostic imaging facilities, and on the front lines, Mirion empowers innovations that move radiation safety, measurement and medicine further to shape our future world. Many of our markets are characterized by the need to meet rigorous regulatory standards, design qualifications, and operating requirements. Throughout our history, we have successfully leveraged the strength of our expertise to continually drive innovation and expand the commercial applications of our core technology competencies.
Quoted from its 10-K, filed 19 Feb 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Information Technology
- Industry
- Electronic Equipment, Instruments & Components
- Listed since
- 29 Jun 2020
- Employees
- 3,281
- Website
- mirion.com ↗
- Head office
- 1218 MENLO DRIVE, ATLANTA, GA, 30318
- Classification
- Measuring & Controlling Devices, NEC
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Mr. Thomas LoganChairman of the Board, Chief Executive Officer, Founder, since 2005$5.8m
- Mr. Brian SchopferChief Financial Officer$2.4m
- Mr. Loic EloyGroup President - Nuclear and Safety$1.1m
- Mrs. Alison UlrichChief Human Resources Officer$724,503
- Ms. Emmanuelle LeeChief Legal Officer, Chief Compliance Office, Deputy General Counsel$994,636
- Mr. Kenneth BockhorstLead Independent Director$244,000
- Mr. Robert CascellaIndependent Director$229,000
- Mr. Steven EtzelIndependent Director$231,500
- Mr. Lawrence KingsleyIndependent Director$216,500
- Mr. John KuoIndependent Director$227,750
- Ms. Jody MarkopoulosIndependent Director$216,500
- Dr. Sheila RegeIndependent Director$216,500
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 46
- Environment
- 16
- Social
- 78
- Governance
- 44
- Women in the workforce
- 26%
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Headquartered in Atlanta, Georgia with a focus on nuclear measurement and detection systems.
- Segments include Medical and Industrial, supporting diverse applications in diagnostics, treatment, and radiation safety.
- Provides dosimetry services, radiation monitoring systems, and specialized equipment for medical and industrial markets.
Weaknesses
- Employment data varies between 3,281 and 2,872 employees, indicating potential inconsistency in reporting.
- The company's IPO date is listed as 2020-06-29, but the source description may not be fully reliable.
- The source description treats the company's information as untrusted, suggesting possible inaccuracies.
Opportunities
- Expanding applications in medical diagnostics and cancer treatment within the Medical segment.
- Growing demand for radiation safety and measurement solutions in nuclear energy and defense sectors.
- Potential for increased market share in electrical penetrations and reactor instrumentation and control equipment.
Threats
- Reliance on untrusted source descriptions may lead to inaccurate financial data interpretation.
- Inconsistent employee count could affect operational planning and resource allocation.
- The company's focus on specialized nuclear systems may limit market diversification.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.